Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07573982 · ClinicalTrials.gov registry record · NA

Ultrasonic Debris Clearance to Promote Brain Resilience

A NA study, sponsored by Stanford University.

Not yet
Registry status
NA
Development phase
15
Enrollment target

NCT07573982: Clinical Trial NA study, sponsored by Stanford University.

NCT07573982 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07573982, a NA study, has not yet begun recruiting, sponsored by Stanford University.

NOT YET RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This pilot study will evaluate the safety, tolerability, and feasibility of Ultrasonic Debris Clearance (UDC), a noninvasive low-intensity focused ultrasound intervention, in amyloid-positive adults who are asymptomatic but at risk for Alzheimer's disease, or who have mild cognitive impairment or mild dementia. The study is designed to test whether repeated UDC sessions can be delivered safely and feasibly in this population, while also exploring efficacy via biomarkers and clinical measures.

Primary Outcome

All reported adverse events including clinically meaningful vital sign changes, laboratory test abnormalities, physical and cognitive symptoms, and new imaging abnormalities not present at baseline.

Interventions

  • DEVICE sham
  • DEVICE Ultrasonic Debris Clearance

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-07
Est. Completion 2027-07
Phase NA
Stanford University

1,744 total trials

What is known before NCT07573982 opens enrollment

NCT07573982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which sham is the first listed.

NCT07573982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07573982 about?

NCT07573982 is a clinical study titled "Ultrasonic Debris Clearance to Promote Brain Resilience". This pilot study will evaluate the safety, tolerability, and feasibility of Ultrasonic Debris Clearance (UDC), a noninvasive low-intensity focused ultrasound intervention, in amyloid-positive adults who are asymptomatic but at risk for Alzheimer's disease, or who have mild cognitive impairment or mi...

What is the current status of trial NCT07573982?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-07. Estimated completion is 2027-07.

What interventions are being tested in trial NCT07573982?

The interventions under investigation include: sham (DEVICE), Ultrasonic Debris Clearance (DEVICE).

Who is sponsoring clinical trial NCT07573982?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07573982's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07573982, the US trial registry maintained by the National Library of Medicine. NCT07573982 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.